LAP Antibodies

Santa Cruz Biotechnology features a diverse variety of LAP Antibodies, specifically targeting the latency-associated peptide (LAP). LAP monoclonal antibodies support multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LAP plays a crucial role in the regulation of immune responses and is involved in the activation of latent transforming growth factor-beta (TGF-β), which is essential for maintaining tissue homeostasis and regulating inflammation. Understanding LAP function is vital for exploring its implications in various diseases, including cancer and fibrosis. LAP research contributes significantly to our knowledge of cellular signaling pathways and their impact on disease progression. Investigating LAP mechanisms provides valuable insights into potential therapeutic strategies for treating inflammatory conditions. Studying LAP interactions helps reveal new aspects of immune system regulation and tissue repair processes. Santa Cruz Biotechnology monoclonal antibodies for LAP research support scientists worldwide in advancing our understanding of fundamental biological processes and potential therapeutic applications.